Lynex is one of the top DEX cum liquidity market on Linea with over 20M in TVL and 2B+ in volume done. The platform supports both concentrated liquidity as well as automated liquidity management strategy to increase yield for the user while reducing loss.
Security:
a) Lynex is based off Thena and Veldorome code. So far there are no known serious hack cases reported for these project. Both have undergone multiple audits and have active bounties
b) Lynex is also independently audited
The Product & Risk Team will review your listing request in their meeting next week. You can expect an update here and on Discord if the team’s analysis concludes that listing Lynex is feasible.
I’ve done a review of Lynex. After talking with the Product & Risk team, I’ve decided to not move forward with a listing. Lynex is a fork, and they’ve only had 1 audit of their codebase outside of the audits on the codebases they’ve forked. Afaik, the GitHub isn’t open source, so I can’t verify what has changed in the code from the Thena codebase. (Somewhat ironic since they forked an open-source project but don’t provide open-source access to their own codebase.) Based on the Secure3 audit, 3 critical and 11 medium severity issues were found, with more lower severity and informational issues. If there were an additional audit, I might be more comfortable with a listing, but given the issues found and the lack of open source access to their GitHub, I can’t verify the quality/security of the codebase.
Lynex also has $22M in TVL, which is on the lower end of what we look for in a listing. If Lynex were to undergo another audit and/or TVL were to grow, I may reconsider a listing. At this time, though, we won’t be listing Lynex.